Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis

Nature Medicine

Volumn 2, Issue 12, 1996, Pages 1354-1360

  Correale, Jorge ^a   Gilmore, Wendy ^a   Lopez, Jerome ^a   Li, Si Q ^a   Mcmillan, Minnie ^a   Weiner, Leslie P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CLONE; CLONAL ANERGY; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; CELL DIVISION; CHRONIC DISEASE; CLONAL ANERGY; FEMALE; HISTOCOMPATIBILITY TESTING; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN PROTEOLIPID PROTEIN; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RNA, MESSENGER; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029822018     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1296-1354     Document Type: Article

References (40)

1. Sinha, A.A., Lopez, M.T. & McDevitt, H.O. Autoimmune diseases: The failure of self tolerance. Science 248, 1380-1387 (1990).
2. Martin, R., McFarland, H.F. & McFarlin, D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153-187 (1992)
3. Marcos, M.A.R. et al. Mutual cell interactions and the selection of immune repertoires: Implication in autoimmunity. Immunol. Today 9, 204-213 (1988).
4. Schwartz, R.H. Acquisition of immunological self-tolerance. Cell 57, 1073-1081 (1989).
5. Blackman, M., Kappler, J. & Marrack, P. The role of the T cell receptor in positive and negative selection of developing T cells. Science 248, 1335-1341 (1990).
6. Blackman, M.A., Finkel, T.H., Kappler, J.W., Cambier, J. & Marrack, P. Altered antigen receptor signaling in anergic T cells from self-tolerant T-cell receptor β-chain transgenic mice. Proc. Natl. Acad. Sci. USA 88, 6682-6686 (1991).
7. Burns, J., Rosenzweig, A., Zweiman, B. & Lisak, R.P. Isolation of myelin basic protein-reactive T cell lines from normal human blood. Cell. Immunol. 81, 435-440 (1983).
8. Correale, J., McMillan, M., McCarthy, K., Le, T. & Weiner, L.P. Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurology 45, 1370-1378 (1995).
9. Kappler, J.W., Staerz, V.D., Steinmetz, M. & von Boehmer, M. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature 332, 35-40 (1988).
10. + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J. Immunol. 146, 1163-1168 (1991).
11. Mosmann, T.R. Cytokine secretion patterns and cross-regulation of T cell subsets. Immunol. Res. 10, 183-188 (1991).
12. Cohen, I.R. & Young, D.B. Autoimmunity, microbial immunity and the immunological homunculus. Immunol. Today 12, 105-110 (1991).
13. Qin, S.X., Cobbold, S., Benjamin, R. & Waldmann, H. Induction of classical transplantation tolerance in the adult. J. Exp. Med. 69, 779-794 (1989).
14. Mueller, D.L., Jenkins, M.K. & Schwartz, R.H. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7, 445-180 (1989).
15. Liu, Y. & Janeway, C.A., Jr. Interferon gamma plays a critical role in induced cell death of effector T cells: A possible third mechanism of self-tolerance. J. Exp. Med. 172, 1735-1739 (1990).
16. Gimmi, C.D. et al. B cell surface antigen B7 provides a costimulatory signal that induces T cell to proliferate and secrete interleukin-2. Proc. Natl. Acad. Sci. USA 88, 6575-6579 (1991).
17. Chen, C. & Nabvi, N. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1, 147-154 (1994).
18. Linsley, P.S. et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792-795 (1992).
19. Lenschow, D.J. et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181, 1145-1155 (1995).
20. Correale, J. et al. Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: Roles of co-stimulatory B7 molecules and IL-12. J. Neuroimmunol. (in the press).
21. Jenkins, M.K., Chen, C., Jung, G., Mueller, D.L. & Schwartz, R.H. Inhibition of antigen specific proliferation of type 1 murine T cell clones after stimulation with antigen and chemically modified antigen presenting cells. J. Immunol. 144, 16-22 (1990).
22. Williams, M.E., Shea, C.M., Lichtman, A.H. & Abbas, A.K. Antigen receptor mediated anergy in resting T lymphocytes and T cell clones. Correlation with lymphokine secretion patterns. J. Immunol. 149, 1921-1926 (1991).
23. O'Hehir, R.E. & Lamb, J.R. Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. Proc. Natl. Acad. Sci. USA 87, 8884-8888 (1990).
24. Jenkins, M.K & Schwartz, R.H. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165, 302-319 (1987).
25. Vandenbark, A.A, Celnik, B., Vainiene, M., Miller, S.D. & Offner, H. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rat through a partial reversible anergy mechanism. J. Immunol. 155, 5861-5867 (1995).
26. Tan, P. et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177, 165-173 (1993).
27. Sayegh, M.H. et al. CD28-B7 blockade after alloantigen challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181, 1869-1874 (1995).
28. Massague, J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6, 597-641 (1990);
29. Miller, S.D. et al. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol. Rev. 144, 225-244 (1995).
30. Olsson, T. et al. Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur. J. Immunol. 22, 1083-1087 (1992).
31. + T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J. Immunol. 151, 7233-7239 (1993).
32. Dayan, C.M., Randall Chu, N., Londei, M., Rapoport, B. & Feldmann, M. T cells involved in human autoimmune disease are resistant to tolerance induction. J. Immunol. 151, 1606-1613 (1993).
33. Miller, S.D. et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3, 739-745 (1995).
34. Kuiper, H.M., Lens, S.M.A., Hintzen, R.Q. & Van Lier, R.A.W. Lymphocyte costimulation: Multiple pathways, multiple functions? Res. Immunol. 146, 180-183 (1995).
35. Van Kemenade, F.J., Kuijpers, K.C., de Waal Malefijt, R., Van Lier, R.A.W. & Miedema, F. Skewing to the LFA-3 adhesion pathway by influenza infection of antigen-presenting cells. Eur. J. Immunol. 23, 635-639 (1993).
36. Kroemer, G. & Martinez-A, C. Mechanisms of self tolerance. Immunol. Today 13, 401-404 (1992).
37. Racke, M.K. et al. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor beta-1. J. Immunol. 146, 3012-3017 (1991).
38. Kadin, M.E. et al. Loss of receptors for transforming growth factor beta in human T cell malignancies. Proc. Natl. Acad. Sci USA 91, 6002-6006 (1994).
39. Hollsberg, P., Augobel, L.J. & Hafler, D.A. Human T cell lymphotropic virus type I-induced T cell activation: Resistance to TGF-beta-1 induced suppression. J. Immunol. 153, 566-573 (1994).
40. Kurtzke, J.F. Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33, 1444-1452 (1983).